Supportive of the functional contribution of the TIME in ING4-deficient tumor progression, low GZMB gene expression together with low ING4 expression was significantly associated with poor patient survival outcomes in the basal subtype of breast cancer. The gene discussed is ING4; the disease is breast cancer.